Cargando…

Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience

BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcy, Pierre-Yves René, Thariat, Juliet, Bozec, Alex, Poissonnet, Gilles, Benisvy, Danielle, Dassonville, Olivier
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674443/
https://www.ncbi.nlm.nih.gov/pubmed/19374744
http://dx.doi.org/10.1186/1477-7819-7-40
_version_ 1782166638058012672
author Marcy, Pierre-Yves René
Thariat, Juliet
Bozec, Alex
Poissonnet, Gilles
Benisvy, Danielle
Dassonville, Olivier
author_facet Marcy, Pierre-Yves René
Thariat, Juliet
Bozec, Alex
Poissonnet, Gilles
Benisvy, Danielle
Dassonville, Olivier
author_sort Marcy, Pierre-Yves René
collection PubMed
description BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of the Antoine Lacassagne Institute. RESULTS: Of 1171 patients with thyroid cancer treated at our institution over the last 18 years, we retrospectively identified nine patients (0.8%), three women and six men, aged 34–81 years (median age: 70 years) presenting with malignant thyroid tumor of median diameter 45 mm (range: 23–87) having venous obstruction of thyroid malignancy origin. Two patients underwent multimodal therapy. All other patients underwent external beam radiation therapy alone ± chemotherapy or palliative care. Ultrasound (US) provided particularly useful information on venous involvement characteristics. Median survival was 7 months and median progression-free survival was 6 months. Survival in our series was worse than that of previously reported series despite diagnosis of vein involvement at an early stage in 2/3 cases using US. CONCLUSION: Despite small numbers of patients, it seems that aggressive treatment modalities including surgery are required to improve survival. In our experience, US was a useful non-invasive method to describe tumor extensions to great veins of the neck (invasion versus compression, tumor thrombus versus blood clot) and should be recommended to depict early venous invasion in cases of suspected thyroid malignancy.
format Text
id pubmed-2674443
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26744432009-04-29 Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience Marcy, Pierre-Yves René Thariat, Juliet Bozec, Alex Poissonnet, Gilles Benisvy, Danielle Dassonville, Olivier World J Surg Oncol Research BACKGROUND AND AIMS: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies (primary or secondary) in our experience and to report patient outcomes. METHODS: Clinical data were collected from the thyroid unit database of the Antoine Lacassagne Institute. RESULTS: Of 1171 patients with thyroid cancer treated at our institution over the last 18 years, we retrospectively identified nine patients (0.8%), three women and six men, aged 34–81 years (median age: 70 years) presenting with malignant thyroid tumor of median diameter 45 mm (range: 23–87) having venous obstruction of thyroid malignancy origin. Two patients underwent multimodal therapy. All other patients underwent external beam radiation therapy alone ± chemotherapy or palliative care. Ultrasound (US) provided particularly useful information on venous involvement characteristics. Median survival was 7 months and median progression-free survival was 6 months. Survival in our series was worse than that of previously reported series despite diagnosis of vein involvement at an early stage in 2/3 cases using US. CONCLUSION: Despite small numbers of patients, it seems that aggressive treatment modalities including surgery are required to improve survival. In our experience, US was a useful non-invasive method to describe tumor extensions to great veins of the neck (invasion versus compression, tumor thrombus versus blood clot) and should be recommended to depict early venous invasion in cases of suspected thyroid malignancy. BioMed Central 2009-04-17 /pmc/articles/PMC2674443/ /pubmed/19374744 http://dx.doi.org/10.1186/1477-7819-7-40 Text en Copyright © 2009 Marcy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Marcy, Pierre-Yves René
Thariat, Juliet
Bozec, Alex
Poissonnet, Gilles
Benisvy, Danielle
Dassonville, Olivier
Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title_full Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title_fullStr Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title_full_unstemmed Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title_short Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience
title_sort venous obstruction of thyroid malignancy origin: the antoine lacassagne institute experience
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674443/
https://www.ncbi.nlm.nih.gov/pubmed/19374744
http://dx.doi.org/10.1186/1477-7819-7-40
work_keys_str_mv AT marcypierreyvesrene venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience
AT thariatjuliet venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience
AT bozecalex venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience
AT poissonnetgilles venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience
AT benisvydanielle venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience
AT dassonvilleolivier venousobstructionofthyroidmalignancyorigintheantoinelacassagneinstituteexperience